Ildong Pharmaceutical buys 36.75 billion won of Aidience RCPS
AI Summary- Ildong Pharmaceutical will acquire Aidience redeemable convertible preferred shares for cash.
- 36.75 billion Korean won will purchase 7,097,016 shares, creating a 13.95% stake.
- Ildong Holdings amended its Series B disclosure, naming Ildong Pharmaceutical as investor.